Cargando…
Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733546/ https://www.ncbi.nlm.nih.gov/pubmed/33316396 http://dx.doi.org/10.1016/j.tmaid.2020.101954 |
| _version_ | 1783622293223636992 |
|---|---|
| author | Million, Matthieu Giraud-Gatineau, Audrey Lagier, Jean-Christophe Parola, Philippe Gautret, Philippe Raoult, Didier |
| author_facet | Million, Matthieu Giraud-Gatineau, Audrey Lagier, Jean-Christophe Parola, Philippe Gautret, Philippe Raoult, Didier |
| author_sort | Million, Matthieu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7733546 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77335462020-12-14 Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin Million, Matthieu Giraud-Gatineau, Audrey Lagier, Jean-Christophe Parola, Philippe Gautret, Philippe Raoult, Didier Travel Med Infect Dis Commentary Elsevier Ltd. 2021 2020-12-13 /pmc/articles/PMC7733546/ /pubmed/33316396 http://dx.doi.org/10.1016/j.tmaid.2020.101954 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Commentary Million, Matthieu Giraud-Gatineau, Audrey Lagier, Jean-Christophe Parola, Philippe Gautret, Philippe Raoult, Didier Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin |
| title | Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin |
| title_full | Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin |
| title_fullStr | Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin |
| title_full_unstemmed | Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin |
| title_short | Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin |
| title_sort | reply to lebeaux d, revest m. no evidence of clinical benefits of early treatment of covid-19 patients with hydroxychloroquine and azithromycin |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733546/ https://www.ncbi.nlm.nih.gov/pubmed/33316396 http://dx.doi.org/10.1016/j.tmaid.2020.101954 |
| work_keys_str_mv | AT millionmatthieu replytolebeauxdrevestmnoevidenceofclinicalbenefitsofearlytreatmentofcovid19patientswithhydroxychloroquineandazithromycin AT giraudgatineauaudrey replytolebeauxdrevestmnoevidenceofclinicalbenefitsofearlytreatmentofcovid19patientswithhydroxychloroquineandazithromycin AT lagierjeanchristophe replytolebeauxdrevestmnoevidenceofclinicalbenefitsofearlytreatmentofcovid19patientswithhydroxychloroquineandazithromycin AT parolaphilippe replytolebeauxdrevestmnoevidenceofclinicalbenefitsofearlytreatmentofcovid19patientswithhydroxychloroquineandazithromycin AT gautretphilippe replytolebeauxdrevestmnoevidenceofclinicalbenefitsofearlytreatmentofcovid19patientswithhydroxychloroquineandazithromycin AT raoultdidier replytolebeauxdrevestmnoevidenceofclinicalbenefitsofearlytreatmentofcovid19patientswithhydroxychloroquineandazithromycin |